This inventor holds 7 USPTO granted patents and 5 published patent applications and 9 EPO patents. Top assignees: Ucb Pharma Gmbh, Schwarz Pharma Ag. Active years: 2010-2016.
Company Filing History:
Years Active: 2010-2016
Title: The Innovations of Thomas Stöhr
Introduction
Thomas Stöhr is a notable inventor based in Monheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of anticonvulsant therapies. With a total of 7 patents to his name, Stöhr's work has the potential to impact the treatment of epilepsy and related conditions.
Latest Patents
Among his latest patents is an innovative pharmaceutical composition aimed at the prevention, alleviation, or treatment of epileptic seizures. This invention involves a combination of a peptide compound and at least one additional compound, showcasing Stöhr's commitment to advancing medical science.
Career Highlights
Stöhr is currently employed at Ucb Pharma GmbH, where he continues to develop groundbreaking therapies. His work at this esteemed company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Dieter Scheller and Christine Rauschkolb-Loeffler. Their combined expertise contributes to the innovative environment at Ucb Pharma GmbH.
Conclusion
Thomas Stöhr's contributions to pharmaceutical innovation, particularly in anticonvulsant therapies, highlight his role as a key inventor in the medical field. His ongoing work promises to enhance treatment options for individuals suffering from epilepsy.